XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Income Statement [Abstract]    
Net sales $ 49,839 $ 50,123
Cost of products sold 37,925 43,927
Gross profit 11,914 6,196
Operating expenses 8,106 6,592
Operating profit (loss) 3,808 (396)
Pension expense (41) (27)
Other income, net 75 467
Interest expense (430) (384)
Profit (loss) before income taxes 3,412 (340)
Income tax expense 897 379
Net earnings (loss) 2,515 (719)
Less: Net earnings attributable to the non-controlling interest 41 28
Net earnings (loss) attributable to Kewaunee Scientific Corporation $ 2,474 $ (747)
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders    
Basic (in dollars per share) $ 0.87 $ (0.27)
Diluted (in dollars per share) $ 0.86 $ (0.27)
Weighted average number of common shares outstanding    
Basic (in shares) 2,860 2,807
Diluted (in shares) 2,885 2,807